Materials and Reagents

10 cm dish
Microcentrifuge tubes
Eppendorf tubes
Agarose beads
U2OS cells
HA-Ubiquitin plasmid
FuGene 6 transfection reagent (Promega Corporation, FuGENE^®, catalog number: E2691 )
Reduced-serum medium (Thermo Fisher Scientific, Gibco^®, catalog number: 31985-070 )
MG132
1x PBS
Trypsin (Thermo Fisher Scientific, Gibco^®, catalog number: 25300 )
IgG control antibody according to the targeted antibody species [e.g., Rabbit IgG (Santa Cruz Biotechnology, catalog number: sc-2027 )]
Agarose conjugate [e.g., Protein A/G agarose (Santa Cruz Biotechnology, catalog number: sc-2003 )]
BRCA1 antibody
RIPA buffer (e.g., Santa Cruz Biotechnology, catalog number: sc-24948 )
Anti-ubiquitin or anti-HA antibody
Tris-HCl
SDS
Bromophenol blue
β-mercaptoethanol
Glycerol
Loading buffer (see Recipes)

Equipment

Tube rotator located in cold room 4 °C
Centrifuges (Eppendorf, model: 5424/5424 R )

Procedure

Co-transfect U2OS cells with HA-Ubiquitin plasmid with other plasmids of interest using FuGene 6. For a 10 cm dish, 3 μg of plasmid is mixed with 18 μl of Fugene 6 in 500 μl Reduced-serum medium, following the manufacturer's recommended procedure for use of Fugene 6. In the representative image, TUSC4 knockdown U2OS cells were used.
After 15-30 min of incubation of the mixture at room temperature, add the mixture drop-wise onto the cell culture media of the 10 cm dish. Gently move the dish around to spread the mixture evenly throughout the dish.
Harvest the cells within 48-72 h (10 µM MG132 incubation for 4-6 h prior to harvest is an optional step that enriches the ubiquitination signal).
Prepare total cell lysate as described under a standard Western blot procedure. In short, wash the cells with 1x PBS and incubate cells with a volume of trypsin that is sufficient to detach the cells from the dish (e.g., 200 µl). Lyse the cells directly on the dish using RIPA buffer (e.g., 500 µl), then transfer the cells to a microcentrifuge tube.
Disrupt the cells with gentle sonication (e.g., 3-sec pulse for 5 times).
Centrifuge the sample at 10,000 x g for 10 min at 4 °C, then transfer the supernatant to a clean microcentrifuge tube on ice, without transferring the cellular debris at the bottom.
(Optional step to reduce non-specific binding) Preclear cell lysate with appropriate IgG mouse control antibody (e.g., 0.25 µg antibody per 1 ml cell lysate), and 20 μl suspended agarose conjugate (e.g., Protein A/G agarose) and rotate mixture at 4 °C for 30 min to 1 h.
Spin down the mixture at 1,000 x g for 1 min at 4 °C and transfer the supernantant containing the targeted protein into a clean microcentrifuge tube (a typical amount of protein is 2-5 mg). Incubate samples with an amount of primary antibody that is suggested by the manufacture at 4 °C with rotation for 2 h to overnight. In the representative image, BRCA1 antibody was used (Lu et al., 2012).
Add 20 µl of appropriate agarose beads and incubate the samples at 4 °C with rotation for 1-2 h.
Spin down the agarose beads at 1,000 x g for 1 min at 4 °C, discard the supernatant with care to not disturb the beads.
Wash the beads with RIPA buffer or PBS 3 times with constant rotation at 4 °C, 15 min each time. RIPA buffer is a relatively strong detergent which can disrupt protein-protein interactions; alternate detergents may be considered for weaker protein-protein interactions. After the last wash, remove as much buffer as possible with minimal disruption of the beads.
Note: In some case, RIPA would be too harsh, so this needs to be adjusted case by case.
Add 20-50 µl of loading buffer and mix to re-suspend the beads. Incubate the samples for 5 min at 95 °C, and then subject to SDS-PAGE analysis or store the samples in -20 °C for future use. In the representative image, a 10% gel was used. Regular western blot condition is sufficient; some blots may require extended wash due to high background that can be caused by non-specific binding during the immunoprecipitation step.
Blots can be probed using anti-ubiquitin or anti-HA antibody to determine the primary proteins’ ubiquitination levels.

Representative data

Figure 1. Knockdown of TUSC4 expression enhanced BRCA1 polyubiquitination, leading to BRCA1 protein degradation

NPRL2/TUSC4 knockdown increased ubiquitination level of BRCA1 compared with control cells (after MG132 enrichment for ubiquitination) (Peng et al., 2015).

Notes

Preclear cell lysate with appropriate IgG control antibody is a necessary step to reduce background signals.

Recipes

Loading buffer
62.5 mM Tris-HCl (pH 6.8)
2.5% SDS
0.002% bromophenol blue
0.7135 M (5%) β-mercaptoethanol
10% glycerol

Acknowledgments

This work was supported by The Department of Defense (DOD) Breast Cancer Research Program (BCRP) Era of Hope Scholar Award (W81XWH-10-1-0558; S.-Y. Lin).

References

Lu, Y., Li, J., Cheng, D., Parameswaren, B., Zhang, S., Jiang, Z.,Yew, P. R., Peng, J., Ye, Q., Hu, Y. (2012). The F-box protein FBXO44 mediates BRCA1 ubiquitination and degradation. J Biol Chem 287:41014-22.
Peng, Y., Dai, H., Wang, E., Lin, C.C., Mo, W., Peng, G., Lin, S.Y. (2015). TUSC4 Functions as a Tumor Suppressor by Regulating BRCA1 Stability. Cancer Res 75(2):378-86.